ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 927,62
0,44%
Dow Jones
44 424,25
-0,32%
DAX
21 394,93
-0,11%
Brent Oil
77,625
0,00%
Bitcoin
104 925,01
0,19%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Hancock Jaffe Laboratories Inc (HJLI) Cours

Hancock Jaffe Laboratories Inc

Hancock Jaffe Laboratories Inc (HJLI)

NASDAQ
10,38
0,00
(0,00%)
Fermé 26 Janvier 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
10,38
Prix Achat
10,00
Prix Vente
10,70
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
98,319M
Clôture Veille
10,38
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
9 472 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,18
Bénéfice par action (BPA)
-2,48
Chiffre d'affairess
-
Bénéfice net
-23,52M

À propos de Hancock Jaffe Laboratories Inc

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
www.envveno.com
Siège social
Wilmington, Delaware, USA
Fondé
-

HJLI Dernières nouvelles

Plus de nouvelles

Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

19 Février 2019
GlobeNewswire Inc.

Hancock Jaffe Announces Objectives for Upcoming CoreoGraft Study

IRVINE, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

28 Janvier 2019
GlobeNewswire Inc.

Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference

IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

15 Janvier 2019
GlobeNewswire Inc.

Hancock Jaffe Announces End Points for First-in-Human VenoValve Study

IRVINE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

09 Janvier 2019
GlobeNewswire Inc.

Hancock Jaffe Receives Approval for First-in-Human VenoValve Study

IRVINE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

17 Décembre 2018
GlobeNewswire Inc.

Hancock Jaffe Announces January CoreoGraft Study at the Texas Heart Institute

IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

04 Décembre 2018
GlobeNewswire Inc.

Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia

IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

20 Novembre 2018
GlobeNewswire Inc.

Hancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance

IRVINE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

13 Novembre 2018
GlobeNewswire Inc.

Hancock Jaffe Enters into Sponsored Research Agreement for CoreoGraft with World-Renowned Texas Heart Institute

IRVINE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

09 Octobre 2018
GlobeNewswire Inc.

Hancock Jaffe Appoints Three New Independent Directors

Accomplished medical device professionals and nationally recognized fund manager and analystbring key experience to the leadership of cardiac and vascular device company IRVINE, Calif., Oct...

02 Octobre 2018
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

HJLI - Frequently Asked Questions (FAQ)

What is the current Hancock Jaffe Laboratories share price?
The current share price of Hancock Jaffe Laboratories is US$ 10,38
How many Hancock Jaffe Laboratories shares are in issue?
Hancock Jaffe Laboratories has 9 472 000 shares in issue
What is the market cap of Hancock Jaffe Laboratories?
The market capitalisation of Hancock Jaffe Laboratories is USD 98,32M
What is the 1 year trading range for Hancock Jaffe Laboratories share price?
Hancock Jaffe Laboratories has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Hancock Jaffe Laboratories?
The price to earnings ratio of Hancock Jaffe Laboratories is -4,18
What is the reporting currency for Hancock Jaffe Laboratories?
Hancock Jaffe Laboratories reports financial results in USD
What is the latest annual profit for Hancock Jaffe Laboratories?
The latest annual profit of Hancock Jaffe Laboratories is USD -23,52M
What is the registered address of Hancock Jaffe Laboratories?
The registered address for Hancock Jaffe Laboratories is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Hancock Jaffe Laboratories website address?
The website address for Hancock Jaffe Laboratories is www.envveno.com
Which industry sector does Hancock Jaffe Laboratories operate in?
Hancock Jaffe Laboratories operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
HJLI
Hancock Jaffe Laboratories
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés